Study of ORL-1M (D-mannose) in Patients With CDG-Ib
Phase 1
- Conditions
- CDG Ib
- Interventions
- Drug: ORL-1M - D-mannose
- First Posted Date
- 2018-01-19
- Last Posted Date
- 2019-01-25
- Lead Sponsor
- Orpha Labs
- Target Recruit Count
- 5
- Registration Number
- NCT03404869
- Locations
- 🇹🇷
Orpha Labs, Ankara, Turkey
Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14
Phase 1
- Conditions
- Glycogen Storage Disease, Type 14
- Interventions
- Drug: ORL-1G - D-galactose
- First Posted Date
- 2018-01-19
- Last Posted Date
- 2019-01-25
- Lead Sponsor
- Orpha Labs
- Target Recruit Count
- 5
- Registration Number
- NCT03404856
- Locations
- 🇹🇷
Orpha Labs, Ankara, Turkey
Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II
- First Posted Date
- 2017-11-28
- Last Posted Date
- 2019-01-25
- Lead Sponsor
- Orpha Labs
- Target Recruit Count
- 4
- Registration Number
- NCT03354533
Study of ORL-1B in Patients With Biotinidase Deficiency
- First Posted Date
- 2017-08-31
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Orpha Labs
- Target Recruit Count
- 20
- Registration Number
- NCT03269045
© Copyright 2025. All Rights Reserved by MedPath